Updates are available Correction dated 2022-02-01
Click to view Correction: https://doi.org/10.1007/s10147-022-02126-8
-
Authors
Yokomizo, Akira http://orcid.org/0000-0002-5741-6280
Yonese, Junji
Egawa, Shin
Fukuhara, Hiroshi
Uemura, Hiroji
Nishimura, Kazuo
Nagata, Masayoshi
Saito, Atsushi
Lee, Takumi
Yamaguchi, Susumu
Nonomura, Norio
-
Funding
Funding for this research was provided by:
Astellas Pharma Inc.
- License Information
-
More Information
Article History
Received: 24 May 2021
Accepted: 30 October 2021
First Online: 15 November 2021
Change Date: 1 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10147-022-02126-8
Declarations
:
: AY has received lecture fees from Astellas, Bayer, and Sanofi. JY has received research funding from Astellas. SE has received a scholarship donation from Astellas, used to fund the research. HF has received funding from Astellas, Bayer, Chugai Pharmaceuticals, Kyorin, MSD, Nippon Shinyaku, Ono Pharmaceutical, Sanofi, and Takeda. HU has received honoraria from Astellas, AstraZeneca, Bayer, FRI-Toyama Chemical, Janssen, Kyowa-Kirin, Sanofi, and Takeda and has received research funding from Bayer, Chugai Pharmaceuticals, FRI-Toyama Chemical, MSD, Sanofi, Taiho, and Takeda. KN reports an advisory role and honoraria from Astellas, an advisory role with AstraZeneca and Janssen, honoraria from Novartis, and research funding from Bayer during the conduct of the study. MN reports his role as principal study investigator during the conduct of this Astellas-sponsored study. AS, TL, and SY are employees of Astellas Pharma Inc. NN has received honoraria from Astellas, AstraZeneca, Jansen, Nippon Shinyaku, and Takeda and research grants from AstraZeneca, Nippon Shinyaku, and Takeda.
